Literature DB >> 220656

ACTH 4-10 in the amelioration of neuropsychological symptomatology associated with senile organic brain syndrome.

R J Branconnier, J O Cole, G Gardos.   

Abstract

Eighteen male and female volunteers over the age of sixty who exhibited mild senile organic brain syndrome were administered ACTH 4-10 (Org OI 63) (30 mg, s.c.) or saline in a 2 X 2 Latin square design. Subjects experienced a reduction in depression and confusion and an increase in vigor. This evidence of an increase in vigor was supported behaviorally by a delay in the onset of increased latency in reaction time. Data also indicated that retrieval from memory may be enhanced by this compound. The electroencephalogram evinced a shift to lower frequencies under ACTH 4-10, but this effect was primarily noted in the females who received drug followed by placebo. These effects of ACTH 4-10 are intriguing and suggest that further work in this area should be encouraged.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 220656     DOI: 10.1007/bf00426731

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  12 in total

1.  Some effects of ACTH 4-10 on performance during a serial reaction task.

Authors:  A W Gaillard; A F Sanders
Journal:  Psychopharmacologia       Date:  1975-05-28

2.  Relationships between age, visual acuity and color vision.

Authors:  A CHAPANIS
Journal:  Hum Biol       Date:  1950-02       Impact factor: 0.553

3.  Cognitive effects of ACTH 4-10 in the elderly.

Authors:  S H Ferris; G Sathananthan; S Gershon; C Clark; J Moshinsky
Journal:  Pharmacol Biochem Behav       Date:  1976       Impact factor: 3.533

4.  Polypeptide influences on attention, memory and anxiety in man.

Authors:  L H Miller; A J Kastin; C A Sandman; M Fink; W J Van Veen
Journal:  Pharmacol Biochem Behav       Date:  1974 Sep-Oct       Impact factor: 3.533

5.  The effects of ACTH- and vasopressin- analogues on CO2-induced retrograde amnesia in rats.

Authors:  H Rigter; H Van Riezen; D De Wied
Journal:  Physiol Behav       Date:  1974-09

6.  EEG analysis based on time domain properties.

Authors:  B Hjorth
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1970-09

7.  Inhibitory effect of ACTH and related peptides on extinction of conditioned avoidance behavior in rats.

Authors:  D de Wied
Journal:  Proc Soc Exp Biol Med       Date:  1966-05

8.  Psycho-physiologic correlates of MSH activity in man.

Authors:  A J Kastin; L H Miller; D Gonzalez-Barcena; W D Hawley; K Dyster-Aas; A V Schally; M L Velasco de Parra; M Velasco
Journal:  Physiol Behav       Date:  1971-12

Review 9.  Chemotherapy in chronic organic brain syndrome--a review of the literature.

Authors:  R F Prien
Journal:  Psychopharmacol Bull       Date:  1973-10

10.  A memory assessment technique for use in geriatric psychopharmacology: drug efficacy trial with naftidrofuryl.

Authors:  R J Branconnier; J O Cole
Journal:  J Am Geriatr Soc       Date:  1977-04       Impact factor: 5.562

View more
  5 in total

Review 1.  Critical review of clinical trials in senile dementia--II.

Authors:  J M Orgogozo; R Spiegel
Journal:  Postgrad Med J       Date:  1987-05       Impact factor: 2.401

2.  Studies on the possible central effects in man of a neuropeptide (ACTH 4-9 analogue).

Authors:  A N Nicholson; B M Stone; S J Jones
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

3.  Influences of peripheral adrenocorticotropin 1-39 (ACTH) and human corticotropin releasing hormone (h-CRH) on human auditory evoked potentials (AEP).

Authors:  J Born; B Bathelt; R Pietrowsky; P Pauschinger; H L Fehm
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

4.  Increased central immunoreactive beta-endorphin content in patients with Wernicke-Korsakoff syndrome and in alcoholics.

Authors:  J A Summers; P T Pullan; J J Kril; C G Harper
Journal:  J Clin Pathol       Date:  1991-02       Impact factor: 3.411

Review 5.  Advances in the pharmacotherapy of Alzheimer's disease.

Authors:  J C Soares; S Gershon
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.